HOME  >  セミナー(最新)  > 2018年01月19日(金)開催 国際シンポジウム 

2018年1月19日(金) 国際シンポジウム L6

A New Horizon of Cancer Immunotherapy
Date : 2018年1月19日(金) 10:00~17:00
  January 19th (Fri), 2018, 10:00-17:00
Venue : 大阪府豊中市新千里東町1-4-2
  5階 山村雄一記念ライフホール
  Senri Life Science Center Building
5th floor “Yuichi Yamamura Memorial Life Hall”
Coordinator : 京都大学 理事・副学長 大学院医学研究科 特命教授
 湊 長博
   Nagahiro Minato (Kyoto University, Japan)
  東京大学医科学研究所 附属病院長
先端医療研究センター 教授
 小澤 敬也
   Keiya Ozawa (The University of Tokyo, Japan)


 Poster(PDF) Program(PDF)
Opening address
Tadamitsu Kishimoto
(President of Senri Life Science Foundation)
Nagahiro Minato
(Graduate School of Medicine, Kyoto University, Japan)
Tumor and host factors regulating anti-tumor immunity and immunotherapy efficacy
Thomas F. Gajewski
(University of Chicago, USA)
Donor-derived immunity in cancer immunotherapy
Johanna Olweus
(Oslo University Hospital Radiumhospitalet, Norway)
Immune Checkpoint Blockade and Beyond in Cancer Immunity
Nagahiro Minato
(Graduate School of Medicine Kyoto University, Japan)
Response and Resistance to PD-1 Blockade Therapy
Antoni Ribas
(Jonsson Comprehensive Cancer Center at UCLA, USA)
Recent trends of clinical gene therapy, focusing on CAR-T cell therapy
Keiya Ozawa
(The Institute of Medical Science, The University of Tokyo, Japan)
CAR T cell therapy beyond the CD19 paradigm
Michel Sadelain
(Memorial Sloan Kettering Cancer Center, USA)
Developing effective adoptive T cell therapy for solid tumors
Daniel J. Powell Jr.
(University of Pennsylvania, USA)
Closing remarks
Keiya Ozawa
(The Institute of Medical Science, The University of Tokyo, Japan)

Unauthorized copying and replication of the contents of this site, text and images are strictly prohibited.